首页> Advanced science (Weinheim, Baden-Wurttemberg, Germany)> S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8<sup>+</sup> T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma.

S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8<sup>+</sup> T Cell-Mediated Anti-Cancer Immunity in Bladder Carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Huihuang,Li

第一单位： Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.;National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.

作者： Huihuang,Li ^[1] ; Jinbo,Chen ^[1] ; Zhenghao,Li ^[2] ; Minfeng,Chen ^[1] ; Zhenyu,Ou ^[1] ; Miao,Mo ^[1] ; Ruizhe,Wang ^[1] ; Shiyu,Tong ^[1] ; Peihua,Liu ^[1] ; Zhiyong,Cai ^[1] ; Chunyu,Zhang ^[1] ; Zhi,Liu ^[1] ; Dingshan,Deng ^[1] ; Jinhui,Liu ^[1] ; Chunliang,Cheng ^[1] ; Jiao,Hu ^[1] ; Xiongbing,Zu ^[1]

作者单位： Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.;National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China. ^[1] Hunan Provincial Key Laboratory of Hepatobiliary Disease Research and Division of Hepato-Biliary-Pancreatic Surgery, Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, China. ^[2]

关键词 S100 family bladder carcinoma effector immune cells immunotherapy tumor microenvironment

医学主题词人类(Humans);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);膀胱(Urinary Bladder);免疫疗法(Immunotherapy);膀胱肿瘤(Urinary Bladder Neoplasms);癌(Carcinoma);肿瘤微环境(Tumor Microenvironment)

DOI 10.1002/advs.202300110

PMID 37414584

发布时间 2024-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交